Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model
暂无分享,去创建一个
F. Villarroya | M. Beal | L. Espinosa | M. Portero-Otín | R. Pamplona | A. Naudí | A. Schlüter | N. Calingasan | J. Galino | A. Pujol | Pablo Ranea-Robles | M. Ruiz | S. Fourcade | I. Ferrer
[1] M. Dewhirst,et al. Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. , 2006, Cancer research.
[2] Z. Dai,et al. Involvement of receptor-interacting protein 140 in palmitate-stimulated macrophage infiltration of pancreatic beta cells , 2017, Experimental and therapeutic medicine.
[3] M. Christian,et al. Distinct functions for RIP140 in development, inflammation, and metabolism , 2013, Trends in Endocrinology & Metabolism.
[4] Z. Dai,et al. RIP140 is Associated with Subclinical Inflammation in Type 2 Diabetic Patients , 2012, Experimental and Clinical Endocrinology & Diabetes (Barth).
[5] Tracy J. Yuen,et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination , 2013, Nature Neuroscience.
[6] M. Christian,et al. The nuclear cofactor receptor interacting protein-140 (RIP140) regulates the expression of genes involved in Aβ generation , 2016, Neurobiology of Aging.
[7] A. Moser,et al. Is microglial apoptosis an early pathogenic change in cerebral X‐linked adrenoleukodystrophy? , 2008, Annals of neurology.
[8] A. Woods,et al. The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. , 2007, Molecular endocrinology.
[9] F. Villarroya,et al. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. , 2013, Human molecular genetics.
[10] B. Weschke,et al. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy , 2018, JAMA network open.
[11] Stéphane Fourcade,et al. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. , 2009, American journal of physiology. Endocrinology and metabolism.
[12] E Vicaut,et al. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. , 2001, American journal of respiratory cell and molecular biology.
[13] Michael S. Becker,et al. TNF‐α mediates mitochondrial uncoupling and enhances ROS‐dependent cell migration via NF‐κB activation in liver cells , 2014, FEBS letters.
[14] A. Fatemi,et al. Dendrimer–N‐acetyl‐L‐cysteine modulates monophagocytic response in adrenoleukodystrophy , 2018, Annals of neurology.
[15] A. Cherniack,et al. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. , 2005, The Journal of clinical investigation.
[16] I. Ferrer,et al. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration. , 2015, Free radical biology & medicine.
[17] M. Portero-Otín,et al. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. , 2011, Antioxidants & redox signaling.
[18] K. Gardiner. Transcriptional Dysregulation in Down Syndrome: Predictions for Altered Protein Complex Stoichiometries and Post-translational Modifications, and Consequences for Learning/Behavior Genes ELK, CREB, and the Estrogen and Glucocorticoid Receptors , 2006, Behavior genetics.
[19] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[20] Norbert Gretz,et al. Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. , 2008, Blood.
[21] M. Schachner,et al. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. , 2002, Human molecular genetics.
[22] H. Stockinger,et al. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes , 2013, Human molecular genetics.
[23] M. Poutanen,et al. The Transcriptional Corepressor RIP140 Regulates Oxidative Metabolism in Skeletal Muscle , 2007, Cell metabolism.
[24] Jean Mosser,et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters , 1993, Nature.
[25] A. Moser,et al. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study , 2019, Neurotherapeutics.
[26] David A. Williams,et al. Hematopoietic Stem‐Cell Gene Therapy for Cerebral Adrenoleukodystrophy , 2017, The New England journal of medicine.
[27] P. Vreken,et al. Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage. , 2005, Human molecular genetics.
[28] M. Beal,et al. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. , 2013, Brain : a journal of neurology.
[29] R. Wanders,et al. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. , 2014, Brain : a journal of neurology.
[30] A. Fischer,et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. , 1990, The New England journal of medicine.
[31] F. Eichler,et al. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. , 2015, The application of clinical genetics.
[32] I. Singh,et al. Pathomechanisms Underlying X‐Adrenoleukodystrophy: A Three‐Hit Hypothesis , 2009, Brain pathology.
[33] D. Greaves,et al. NF-κB-mediated degradation of the co-activator RIP140 regulates inflammatory response and contributes to endotoxin tolerance , 2012, Nature Immunology.
[34] H. Moser,et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.
[35] W. Köhler,et al. Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X‐linked adrenoleukodystrophy , 2018, Journal of inherited metabolic disease.
[36] E. Galea,et al. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy , 2016, Acta Neuropathologica.
[37] F. Villarroya,et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. , 2008, Human molecular genetics.
[38] T. Mak,et al. TNF and ROS Crosstalk in Inflammation. , 2016, Trends in cell biology.
[39] M. Zannini,et al. NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome. , 2014, Human molecular genetics.
[40] J. Mandel,et al. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. , 2004, Human molecular genetics.
[41] N. Popitsch,et al. Impaired plasticity of macrophages in X-linked adrenoleukodystrophy , 2018, Brain : a journal of neurology.
[42] I. Rosewell,et al. The nuclear receptor co-repressor Nrip1 (RIP140) is essential for female fertility , 2000, Nature Medicine.
[43] M. Beal,et al. High‐dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy , 2020, Brain pathology.
[44] A. Moser,et al. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy. , 2020, Free radical biology & medicine.
[45] Manfred Schmidt,et al. Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.
[46] P. So,et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Moser,et al. Newborn Screening and Emerging Therapies for X-Linked Adrenoleukodystrophy. , 2018, JAMA neurology.
[48] J. Nautiyal. Transcriptional coregulator RIP140: an essential regulator of physiology. , 2017, Journal of molecular endocrinology.
[49] Li-Na Wei,et al. Receptor-interacting protein 140 as a co-repressor of Heat Shock Factor 1 regulates neuronal stress response , 2017, Cell Death & Disease.
[50] I. Ferrer,et al. Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy , 2014, Acta Neuropathologica.
[51] Shelly K McCrady-Spitzer,et al. Reducing RIP140 Expression in Macrophage Alters ATM Infiltration, Facilitates White Adipose Tissue Browning, and Prevents High-Fat Diet–Induced Insulin Resistance , 2014, Diabetes.
[52] H. Lassmann,et al. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency , 2007, Acta Neuropathologica.
[53] T. Maurice,et al. Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression , 2012, Genes, brain, and behavior.
[54] B. Poll-The,et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management , 2012, Orphanet Journal of Rare Diseases.
[55] F. Villarroya,et al. Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy. , 2015, Human molecular genetics.
[56] S. Herzig,et al. Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice , 2008, Hepatology.
[57] F. Eichler,et al. Microglial dysfunction as a key pathological change in adrenomyeloneuropathy , 2017, Annals of neurology.
[58] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[59] Li-Na Wei,et al. Receptor-Interacting Protein 140 Orchestrates the Dynamics of Macrophage M1/M2 Polarization , 2015, Journal of Innate Immunity.
[60] F. Kelly,et al. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy , 2011, Human molecular genetics.
[61] C. Cervellati,et al. 4-hydroxynonenal protein adducts: Key mediator in Rett syndrome oxinflammation. , 2017, Free radical biology & medicine.
[62] I. Ferrer,et al. General Aspects and Neuropathology of X‐Linked Adrenoleukodystrophy , 2009, Brain pathology.
[63] H. Werner,et al. Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice , 2014, PloS one.
[64] D. Butterfield,et al. Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia , 2011, Current gerontology and geriatrics research.
[65] M. Portero-Otín,et al. Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy , 2011, Annals of neurology.
[66] M. Beal,et al. Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy , 2018, EMBO molecular medicine.
[67] I. Ferrer,et al. Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy. , 2013, Brain : a journal of neurology.
[68] Mara Dierssen,et al. Opposite Phenotypes of Muscle Strength and Locomotor Function in Mouse Models of Partial Trisomy and Monosomy 21 for the Proximal Hspa13-App Region , 2015, PLoS genetics.
[69] M. Beal,et al. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy , 2015, Cell Death and Differentiation.